MENU

Why Cann Group Ltd shares jumped 35% to a record-high today

The Cann Group Ltd (ASX: CAN) share price has built on its early gains and pushed significantly higher in late morning trade.

At one stage the medicinal cannabis company’s shares were up over 35% to a record high of $3.90. It has since given back a bit of this gain, but still sits higher by 29% at $3.70.

Incredibly this means that Cann Group’s shares have rallied a massive 1,130% since listing on the ASX at 30 cents per share in May of last year.

What happened?

As I mentioned earlier, Australian pot stocks have stormed higher today after the Federal Government changed regulations to allow the export of medicinal cannabis.

Health Minister Greg Hunt made the decision in order to help the developing domestic medicinal cannabis market to grow further.

Whilst this is a major positive for all pot stocks, including the likes of Auscann Group Holdings Ltd (ASX: AC8) and Creso Pharma Ltd (ASX: CPH), investors appear to be betting on Cann Group being a big winner due to its sizeable production capacity.

Cann Group recently commissioned its second production facility and is progressing plans to develop a 16,000m2 state of the art cultivation, research and development, and manufacturing facility as part of its phase three expansion. The new facility will incorporate approximately 9,600m2 of “flowering” production area.

Is it too late to invest?

With a market capitalisation approaching $400 million, there certainly is a lot of future growth built into Cann Group’s share price now. This does make a risky proposition for investors.

I would suggest investors hold off an investment in Cann Group for the time being and wait to see how things unfold over the next few months. I suspect profit-taking could present investors with better entry points in the future.

In the meantime I think investors would do very well from investments in these exciting tech shares.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We're living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That's why at The Motley Fool we've been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We've found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.